3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
110
Carcinoma, Intraductal, Noninfiltrating
7
Breast Carcinoma In Situ
6
Neoplasms
4
Neoplasm Metastasis
3
Inflammatory Breast Neoplasms
3
Carcinoma, Ductal, Breast
3
Breast Neoplasms, Male
3
Infertility
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Breast Cancer Female
2
Sleep Wake Disorders
1
Quality of Life
1
Pulmonary Fibrosis
1
Prostatic Neoplasms
1
Primary Breast Cancer
1
Polycystic Ovary Syndrome
1
Paget's Disease, Mammary
1
Ovarian Neoplasms
1
Obesity
1
Neoplasm Recurrence, Local
1
Liver Neoplasms
1
Hot Flashes
1
Fatigue
1
Cardiotoxicity
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Lobular
1
Carcinoma, Hepatocellular
1
Breast Cancer Subjects
1
Interventions
exemestane
1
Valeriana extract
1
Triptorelin Pamoate
1
Tamoxifen
1
Melatonin
1
Gonadotropin-Releasing Hormone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Sleep Wake Disorders
×
Tamoxifen
×
Clear all
NCT00659373
2016-07-25
Co-SOFT
ETOP IBCSG Partners Foundation
Phase 3
Completed
86 enrolled
4 charts